Their mode of action is inclusive of increasing release of insulin in a glucose-dependent manner, thereby lowering the risk of hypoglycemia as compared to the other anti-diabetic agents
Zepbound, Foundayo, and Wegovy will be covered
What makes GLP-1 medications revolutionary is their ability to address the biological drivers of obesity not just willpower or caloric math
This mechanistic depth is the basis for Phase 2 outcomes that exceeded all prior single- or dual-agonist research
Karasik saidthat study participants with lower adherence, in general, will see their glucose levels rise with time, and this was observed in the study
For those with more intense weight loss goals, you can try 2,000 mg per day, but its always a good idea to listen to your body and adjust accordingly